Amneal Pharmaceuticals (AMRX) FCF Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly FCF Margin of 4.83% for Q1 2026, down 401.0% year-over-year from 1.61% in Q1 2025, and down 136.26% quarter-over-quarter from 13.33% in Q4 2025.
Amneal Pharmaceuticals (AMRX) FCF Margin (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' FCF Margin history runs 10 years deep, the most recent figure standing at 4.83% for Q1 2026.
- In Q1 2026, FCF Margin fell 401.0% year-over-year to 4.83%; the TTM figure through Mar 2026 stood at 7.9% (down 97.0% YoY), while the FY2025 annual figure was 8.94%, up 24.0% from the prior year.
- FCF Margin for Q1 2026 stood at 4.83%, down from 13.33% in the prior quarter.
- The five-year high for FCF Margin was 23.32% in Q1 2023, with the low at 23.34% in Q2 2022.
- The 5-year median for FCF Margin is 11.25% (2023), against an average of 7.6%.
- The sharpest annual moves came in 2023 and 2024: FCF Margin surged 1945 bps in 2023, then plunged 2539 bps in 2024.
- Amneal Pharmaceuticals' FCF Margin stood at 2.2% in 2022, then surged by 830 bps to 20.42% in 2023, then sank by 31 bps to 14.09% in 2024, then retreated by 5 bps to 13.33% in 2025, then tumbled by 136 bps to 4.83% in 2026.
- Business Quant data shows AMRX's FCF Margin at 4.83% in Q1 2026, 13.33% in Q4 2025, and 13.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | -6.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.52% |
| Mar 31, 2026 | -4.83% |
| Dec 31, 2025 | 13.33% |
| Sep 30, 2025 | 13.53% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -0.83% |
| Dec 31, 2024 | 14.09% |
| Sep 30, 2024 | 17.77% |
| Jun 30, 2024 | 4.14% |
| Mar 31, 2024 | -2.06% |
| Dec 31, 2023 | 20.42% |
| Sep 30, 2023 | 11.25% |
| Jun 30, 2023 | -3.90% |
| Mar 31, 2023 | 23.32% |
| Dec 31, 2022 | 2.20% |
| Sep 30, 2022 | 13.65% |
| Jun 30, 2022 | -23.34% |
| Mar 31, 2022 | 22.01% |
| Dec 31, 2021 | 8.52% |
| Sep 30, 2021 | 13.57% |